APT Medical Inc. (SHA:688617)

APT Medical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	33,811	34,308	36,094	25,854	20,463	18,668
Market Cap Growth	-21.60%	-4.95%	39.61%	26.35%	9.62%	-
Enterprise Value	32,433	33,003	35,194	24,788	19,457	17,519
Last Close Price	242.85	242.26	254.60	182.44	143.51	130.20

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	36.76	41.81	53.62	48.42	57.16	89.78
Forward PE	33.90	33.30	41.69	41.48	50.33	65.88
PS Ratio	11.67	13.28	17.47	15.67	16.83	22.53
PB Ratio	10.84	10.96	14.13	13.18	11.43	10.42
P/TBV Ratio	12.73	12.95	17.47	14.56	11.87	10.69
P/FCF Ratio	39.54	50.29	387.51	53.09	91.25	1332.38
P/OCF Ratio	31.53	35.45	48.55	37.52	55.69	102.92

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	11.20	12.77	17.04	15.02	16.00	21.14
EV/EBITDA Ratio	28.81	33.39	44.49	42.67	47.96	86.10
EV/EBIT Ratio	32.16	37.17	49.32	47.23	53.31	99.72
EV/FCF Ratio	37.93	48.38	377.84	50.90	86.76	1250.43

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.00	0.01	0.00	0.05	0.03	0.03
Debt / EBITDA Ratio	0.01	0.02	0.01	0.15	0.13	0.22
Debt / FCF Ratio	0.02	0.03	0.12	0.19	0.24	3.32
Net Debt / Equity Ratio	-0.45	-0.48	-0.42	-0.63	-0.60	-0.66
Net Debt / EBITDA Ratio	-1.26	-1.51	-1.35	-2.15	-2.66	-5.78
Net Debt / FCF Ratio	-1.65	-2.19	-11.48	-2.56	-4.81	-83.99
Asset Turnover	0.85	0.78	0.74	0.69	0.57	0.64
Inventory Turnover	1.72	1.59	1.60	1.46	1.18	1.27
Quick Ratio	3.45	3.50	2.92	2.36	2.90	6.53
Current Ratio	4.67	4.62	3.98	2.99	3.78	7.98
Return on Equity (ROE)	30.82%	28.42%	29.14%	27.82%	18.99%	17.39%
Return on Assets (ROA)	18.43%	16.74%	16.06%	13.67%	10.76%	8.44%
Return on Invested Capital (ROIC)	50.70%	49.11%	57.22%	64.41%	47.40%	31.43%
Return on Capital Employed (ROCE)	31.70%	27.80%	27.70%	26.40%	20.10%	9.70%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	2.76%	2.39%	1.86%	2.07%	1.75%	1.11%
FCF Yield	2.53%	1.99%	0.26%	1.88%	1.10%	0.07%
Dividend Yield	0.41%	0.41%	0.47%	0.52%	0.55%	0.36%
Payout Ratio	14.92%	20.75%	19.90%	21.02%	19.28%	15.96%
Buyback Yield / Dilution	0.26%	-0.05%	0.27%	0.16%	-2.99%	-31.45%
Total Shareholder Return	0.66%	0.36%	0.74%	0.69%	-2.44%	-31.09%

Data Source: S&P Global Market Intelligence Last updated: Aug 19, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error